Copyright
©The Author(s) 2021.
World J Diabetes. Jan 15, 2021; 12(1): 19-46
Published online Jan 15, 2021. doi: 10.4239/wjd.v12.i1.19
Published online Jan 15, 2021. doi: 10.4239/wjd.v12.i1.19
Figure 7 Expression of miR-155-5p induced by high glucose treatment for different durations.
Rat mesangial cells (RMCs) cultured under normal-glucose (NG, 5.5 mmol/L glucose) and high-glucose (HG, 30 mmol/L glucose) conditions were treated with high glucose concentrations for 0.25, 0.5, 1, 2, 4, 8, 12, 24, 36, and 48 h. The expression of miR-155-5p increased beginning at 0.25 h and peaked after 4 h. aP < 0.05 compared with RMCs cultured with normal glucose concentrations. The expression of miR-155-5p was quantified using real-time polymerase chain reaction. The results were normalized to the expression of the U6 mRNA and are presented as the mean ± SD of six independent experiments.
- Citation: Zhou Y, Ma XY, Han JY, Yang M, Lv C, Shao Y, Wang YL, Kang JY, Wang QY. Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop. World J Diabetes 2021; 12(1): 19-46
- URL: https://www.wjgnet.com/1948-9358/full/v12/i1/19.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i1.19